Tanios Bekaii-Saab, MD, FACP

Co-Leader, Gastrointestinal Cancer Program
Mayo Clinic Cancer Center
Senior Associate Consultant
Division of Hematology and Oncology
Mayo Clinic
Phoenix, Arizona

Dr. Tanios Bekaii-Saab earned his medical degree from the American University of Beirut in Lebanon, followed by a residency in internal medicine at Indiana University Medical Center in Indianapolis, Indiana. He completed fellowships in clinical pharmacology and experimental therapeutics and hematology/oncology at Tufts University/New England Medical Center in Boston, Massachusetts. Dr. Bekaii-Saab joined the faculty at the Mayo Clinic in May 2016 as Co-Leader of the Gastrointestinal Cancer Program at the Mayo Clinic Cancer Center, and Senior Associate Consultant, Division of Hematology and Oncology. He was previously at Ohio State University - Arthur G. James Cancer Hospital and Solove Research Institute as a tenured Professor of Medicine and Pharmacy, and Section Chief for the Gastrointestinal Cancer Program.

Dr. Bekaii-Saab is actively involved in the American Society of Clinical Oncology, American Association for Cancer Research, American Society for Clinical Pharmacology and Therapeutics, and the Alliance cooperative group. He also serves as a member on the Colorectal Cancer Panel for the National Comprehensive Cancer Network (NCCN). In addition, he has served as a reviewer for more than 50 journals, as journal editorial board member of Journal of the National Comprehensive Cancer Network, World Journal of Hepatology, US Oncological Review, and OncLive, and has authored more than 350 publications and abstracts in journals including Journal of Clinical Oncology, Annals of Oncology, and Clinical Cancer Research.

Dr. Bekaii-Saab’s research interests include experimental therapeutics/translational research focused on gastrointestinal malignancies, molecular targeted and immune therapies, including various collaborations with a number of scientists from different laboratories. He is the principal investigator on numerous clinical trials supported through research grants from the National Cancer Institute (NCI) and the NCCN. He is also the recipient of numerous research grants from various industry partners. Dr. Bekaii-Saab is also the recipient of the prestigious NCI clinical investigator team leadership award and the ASCO leadership program development award. Additionally, he has been listed in U.S. News and World Report’s Top Doctors and is one of the Best Doctors in America.

Last modified: August 5, 2016

Partners in Pancreatic Cancer would like to recognize and thank Celgene Corporation
for their educational support of PartnersinPancreaticCancer.com.

©2017 MediCom Worldwide, Inc. All rights reserved